The rise of the Web promised great upside for media companies: expanding markets, declining distribution costs, the chance to offer new products and services.

If your changes are of general interest and sufficient quality, there's a good chance they'll be integrated into the GTK + main distribution.

Another attraction of the deal, Mr Kindler argued, is the chance to fill Pfizer's flagging distribution channels and weak research pipelines with fresh products.